Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LRRK2 | Q5S007 | 5/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | ASPH | Q12797 | 1/20 | 0.32 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.32 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.32 |
| ▸ | MBOAT4 | Q96T53 | 2/20 | 0.32 |
| ▸ | GABBR2 | O75899 | 3/20 | 0.32 |
| ▸ | GABBR1 | Q9UBS5 | 3/20 | 0.32 |
| ▸ | SORT1 | Q99523 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | ULK1 | O75385 | 1/20 | 0.32 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.32 |
| ▸ | AURKA | O14965 | 1/20 | 0.31 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.31 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL28557230 | 0.98 | LRRK2 (0.34) | LRRK2CYP1A2HPGDHSD17B10ASPH | |
| SCHEMBL12264117 | 0.79 | LMNA (0.31) | — | |
| SCHEMBL10206571 | 0.78 | NFKB1 (0.43) | LRRK2CYP1A2MBOAT4 | |
| SCHEMBL15502332 | 0.78 | MBOAT4 (0.40) | LRRK2CYP1A2MBOAT4NR1H2 | |
| SCHEMBL31125220 | 0.78 | KDM4E (0.44) | HPGDHSD17B10HSP90AA1HSP90AB1MBOAT4 | |
| SCHEMBL5019496 | 0.78 | KDM4E (0.44) | HPGDHSD17B10HSP90AA1HSP90AB1MBOAT4 | |
| SCHEMBL15502285 | 0.78 | HPGD (0.32) | LRRK2CYP1A2HPGDHSD17B10ASPH | |
| SCHEMBL9283648 | 0.78 | AURKA (0.43) | HPGDHSD17B10HSP90AA1HSP90AB1MBOAT4 | |
| SCHEMBL13674954 | 0.78 | LRRK2 (0.33) | LRRK2CYP1A2HPGDHSD17B10ASPH | |
| SCHEMBL16476936 | 0.77 | HPGD (0.31) | LRRK2CYP1A2HPGDHSD17B10ASPH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230293519-A1 | INTEGRIN INHIBITORS AND USES THEREOF IN COMBINATION WITH OTHER AGENTS | PLIANT THERAPEUTICS INC (US) | 2023-09-21 | — | — | US | disclosed |
| US-20230293519-A1 | INTEGRIN INHIBITORS AND USES THEREOF IN COMBINATION WITH OTHER AGENTS | PLIANT THERAPEUTICS INC (US) | 2023-09-21 | — | — | US | disclosed |
| EP-4186895-A1 | COMPOUND USEFUL AS CDK7 KINASE INHIBITOR AND USE THEREOF | TYK Medicines Inc. (CN) | 2023-05-31 | — | — | EP | disclosed |
| EP-3421465-B1 | RHO-ASSOCIATED PROTEIN KINASE INHIBITOR, PHARMACEUTICAL COMPOSITION COMPRISING THE SAME, AS WELL AS PREPARATION METHOD AND USE THEREOF | BEIJING TIDE PHARMACEUTICAL CO LTD (CN) | 2022-10-26 | — | — | EP | disclosed |
| WO-2022068849-A1 | BIFUNCTIONAL COMPOUNDS FOR DEGRADATION OF EGFR AND RELATED METHODS OF USE | BEIGENE, LTD. (KY) | 2022-04-07 | — | — | WO | disclosed |
| EP-3057956-B1 | POLYCYCLIC INHIBITORS OF CYCLIN-DEPENDENT KINASE 7 (CDK7) | DANA FARBER CANCER INST INC (US) | 2021-05-05 | — | — | EP | disclosed |
| EP-3421465-A1 | RHO-ASSOCIATED PROTEIN KINASE INHIBITOR, PHARMACEUTICAL COMPOSITION COMPRISING THE SAME, AS WELL AS PREPARATION METHOD AND USE THEREOF | Beijing Tide Pharmaceutical Co., Ltd. (CN) | 2019-01-02 | — | — | EP | disclosed |
| WO-2018029288-A1 | SULFONYL PYRIDYL TRP INHIBITORS | F. HOFFMANN-LA ROCHE AG (CH) | 2018-02-15 | — | — | WO | disclosed |
| US-20160264567-A1 | SUBSTITUTED SULFONAMIDE COMPOUNDS | GENENTECH, INC. (US) | 2016-09-15 | — | — | US | disclosed |
| US-20160264554-A1 | POLYCYCLIC INHIBITORS OF CYCLIN-DEPENDENT KINASE 7 (CDK7) | DANA-FARBER CANCER INSTITUTE, INC. | 2016-09-15 | — | — | US | disclosed |
| US-8729265-B2 | Regioselective preparation of 2-amino-5-trifluoromethylpyrimidine derivatives | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2014-05-20 | — | — | US | disclosed |
| US-20130079518-A1 | REGIOSELECTIVE PREPARATION OF SUBSTITUTED PYRIMIDINES | LINZ GUENTER (DE) | 2013-03-28 | — | — | US | disclosed |
| US-20130079519-A1 | REGIOSELECTIVE PREPARATION OF SUBSTITUTED PYRIMIDINES | DURAN ADIL (DE) | 2013-03-28 | — | — | US | disclosed |
| US-8372974-B2 | Regioselective preparation of substituted pyrimidines | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2013-02-12 | — | — | US | disclosed |
| US-8334383-B2 | Regioselective preparation of substituted pyrimidines | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2012-12-18 | — | — | US | disclosed |
| US-20120172596-A1 | REGIOSELECTIVE PREPARATION OF 2-AMINO-5-TRIFLUOROMETHYLPYRIMIDINE DERIVATIVES | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2012-07-05 | — | — | US | disclosed |
| US-20110190499-A1 | SELECTIVE SYNTHESIS OF FUNCTIONALIZED PYRIMIDINES | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2011-08-04 | — | — | US | disclosed |
| US-20110077403-A1 | REGIOSELECTIVE PREPARATION OF SUBSTITUTED PYRIMIDINES | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2011-03-31 | — | — | US | disclosed |
| US-20110060141-A1 | REGIOSELECTIVE PREPARATION OF SUBSTITUTED PYRIMIDINES | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2011-03-10 | — | — | US | disclosed |
| WO-2010046035-A1 | SULFOXIMINE-SUBSTITUTED ANILINOPYRIMIDINE DERIVATIVES AS CDK INHIBITORS, THE PRODUCTION THEREOF, AND USE AS MEDICINE | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2010-04-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110190499-A1 | SELECTIVE SYNTHESIS OF FUNCTIONALIZED PYRIMIDINES | DPYD, TYMS, UMPS | LRRK2 3524/4885CYP1A2 303/4885HPGD 819/4885 |
| US-20230293519-A1 | INTEGRIN INHIBITORS AND USES THEREOF IN COMBINATION WITH OTHER AGENTS | ITGB6, ITGA5, ITGAV | LRRK2 1844/4885CYP1A2 4411/4885HPGD 3044/4885 |
| US-20160264554-A1 | POLYCYCLIC INHIBITORS OF CYCLIN-DEPENDENT KINASE 7 (CDK7) | CDK13, CDK3, CDK12 | LRRK2 2867/4885CYP1A2 1117/4885HPGD 3548/4885 |
| US-20110060141-A1 | REGIOSELECTIVE PREPARATION OF SUBSTITUTED PYRIMIDINES | TYMS, DPYD, TYMP | LRRK2 3870/4885CYP1A2 261/4885HPGD 993/4885 |
| US-20160264567-A1 | SUBSTITUTED SULFONAMIDE COMPOUNDS | TRPA1, TRPV1, TRPV5 | LRRK2 4378/4885CYP1A2 427/4885HPGD 1178/4885 |
| US-20110077403-A1 | REGIOSELECTIVE PREPARATION OF SUBSTITUTED PYRIMIDINES | TYMS, DPYD, TYMP | LRRK2 3870/4885CYP1A2 261/4885HPGD 993/4885 |
| US-20120172596-A1 | REGIOSELECTIVE PREPARATION OF 2-AMINO-5-TRIFLUOROMETHYLPYRIMIDINE DERIVATIVES | DPYD, HRH2, TYMS | LRRK2 1764/4885CYP1A2 513/4885HPGD 259/4885 |
| US-20130079518-A1 | REGIOSELECTIVE PREPARATION OF SUBSTITUTED PYRIMIDINES | TYMS, DPYD, TYMP | LRRK2 3850/4885CYP1A2 236/4885HPGD 943/4885 |
| US-20130079519-A1 | REGIOSELECTIVE PREPARATION OF SUBSTITUTED PYRIMIDINES | TYMS, DPYD, TYMP | LRRK2 3850/4885CYP1A2 236/4885HPGD 943/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.